GoodRx Holdings, Inc. (GDRX) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1251030,
    "name": "GoodRx Holdings, Inc.",
    "stock_name": "GoodRx Holdings, Inc.",
    "full_name": "GoodRx Holdings, Inc.",
    "name_url": "stocks-analysis/goodrx-holdings-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "2.75",
    "chg": 0.07,
    "chgp": "2.61%",
    "dir": 1,
    "prev_price": "2.68",
    "mcapval": "1,431.49",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Computers - Software & Consulting",
    "ind_code": 3320,
    "indexname": "S&P 500",
    "isin": "US38246G1085",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "2.82 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/goodrx-holdings-inc-1251030-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is GoodRx Holdings, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-goodrx-holdings-inc-overvalued-or-undervalued-3723426",
        "imagepath": "",
        "date": "2025-11-23 11:12:38",
        "description": "As of 21 November 2025, the valuation grade for GoodRx Holdings, Inc. has moved from attractive to very attractive. Despite this positive change, the company appears to be overvalued based on its current P/E ratio of 38, which is significantly higher than the peer average of approximately 31.76 for similar companies. Additionally, the EV to EBITDA ratio stands at 9.64, indicating a premium compared to some peers, while the Price to Book Value is 2.23, suggesting that the market is pricing the stock at a higher value relative to its book value.\n\nWhen compared to its peers, GoodRx's valuation ratios indicate a disparity, particularly against PropertyGuru Group Ltd. and ZipRecruiter, Inc., which have P/E ratios of -132.05 and -12.45, respectively. This context highlights that GoodRx's valuation may not be justified given its performance metrics, such as a ROE of 5.92% and a ROCE of 11.40%. Furthermore, the com..."
      },
      {
        "title": "GoodRx Holdings Hits 52-Week Low at $3.21 Amidst Significant Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/goodrx-holdings-hits-52-week-low-at-321-amidst-significant-decline-3674069",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/GoodRxHoldingsI_priceRelatedfactors_3674069.png",
        "date": "2025-11-05 16:53:33",
        "description": "GoodRx Holdings, Inc. has hit a new 52-week low, reflecting a significant decline over the past year. Despite this downturn, the company reported positive financial metrics, including strong operating cash flow and net profit. Institutional investors maintain a substantial stake, indicating confidence in its fundamentals."
      },
      {
        "title": "GoodRx Holdings Hits 52-Week Low at $3.25 Amid Significant Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/goodrx-holdings-hits-52-week-low-at-325-amid-significant-decline-3671542",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/GoodRxHoldingsI_priceRelatedfactors_3671542.png",
        "date": "2025-11-04 18:04:29",
        "description": "GoodRx Holdings, Inc. has reached a new 52-week low, reflecting a significant decline over the past year. Despite this downturn, the company reported strong financial metrics, including high operating cash flow and net profit. GoodRx also has a substantial market capitalization and high institutional ownership, indicating investor confidence."
      },
      {
        "title": "Is GoodRx Holdings, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-goodrx-holdings-inc-overvalued-or-undervalued-3638018",
        "imagepath": "",
        "date": "2025-10-21 12:13:36",
        "description": "As of 17 October 2025, GoodRx Holdings, Inc. has moved from an attractive to a fair valuation grade. The company appears to be overvalued based on its current metrics. Key ratios include a P/E ratio of 38, a Price to Book Value of 2.23, and an EV to EBITDA of 9.64, which suggest that the stock is priced higher relative to its earnings and book value compared to its peers.\n\nIn comparison to its peers, GoodRx's P/E ratio of 31.76 is significantly better than PropertyGuru Group Ltd., which has a P/E of -132.05, indicating that GoodRx is relatively more stable in terms of earnings. However, the overall industry context suggests that GoodRx is not a strong performer, especially when considering its recent stock performance; it has underperformed the S&P 500 across multiple time frames, including a staggering -44.33% return over the past year compared to the S&P 500's 14.08%...."
      },
      {
        "title": "Is GoodRx Holdings, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-goodrx-holdings-inc-overvalued-or-undervalued-3634888",
        "imagepath": "",
        "date": "2025-10-20 12:30:49",
        "description": "As of 17 October 2025, GoodRx Holdings, Inc. has moved from an attractive to a fair valuation grade. Based on the current metrics, the company appears to be fairly valued. The P/E ratio stands at 38, which is significantly higher than the peer average of approximately 31.76 for GoodRx, while the EV to EBITDA ratio of 9.64 is more favorable compared to the industry average. Additionally, the Price to Book Value is 2.23, indicating a reasonable valuation relative to its book value.\n\nIn comparison to its peers, GoodRx Holdings, Inc. has a more favorable EV to EBITDA ratio than PropertyGuru Group Ltd., which has a ratio of 144.58, and significantly better than other risky peers like ZipRecruiter, Inc. and Cardlytics, Inc. Despite the lack of recent return data, the absence of a notable return comparison against the S&P 500 suggests that the stock's performance may not have been particularly strong, which aligns..."
      },
      {
        "title": "Is GoodRx Holdings, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-goodrx-holdings-inc-overvalued-or-undervalued-3632427",
        "imagepath": "",
        "date": "2025-10-19 12:08:03",
        "description": "As of 17 October 2025, the valuation grade for GoodRx Holdings, Inc. has moved from attractive to fair. The company appears to be overvalued based on its current metrics. Key ratios include a P/E ratio of 38, a Price to Book Value of 2.23, and an EV to EBITDA of 9.64, which are relatively high compared to peers like PropertyGuru Group Ltd. with a P/E of -132.05 and ZipRecruiter, Inc. with a P/E of -12.45, both indicating significant challenges in their valuations.\n\nGoodRx has experienced substantial declines in stock performance, with a 1-year return of -44.33% compared to the S&P 500's 14.08%, and a staggering 5-year return of -92.78% against the S&P 500's 91.29%. This stark contrast reinforces the notion that GoodRx is currently overvalued in its market position...."
      },
      {
        "title": "GoodRx Holdings, Inc. Experiences Valuation Adjustment Amidst Competitive Market Landscape",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/goodrx-holdings-changes-valuation-grade-from-fair-to-expensive-amid-market-volatility-3600820",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/GoodRxHoldingsI_valuationdot_3600820.png",
        "date": "2025-10-07 19:12:56",
        "description": "GoodRx Holdings, Inc. has recently adjusted its valuation, with a P/E ratio of 38 and a Price to Book Value of 2.23. The company shows mixed performance metrics, including a year-to-date return of -1.51% and a decline of 35.40% over the past year, compared to the S&P 500."
      },
      {
        "title": "Is GoodRx Holdings, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-goodrx-holdings-inc-overvalued-or-undervalued-3591477",
        "imagepath": "",
        "date": "2025-10-05 11:16:40",
        "description": "As of 3 October 2025, the valuation grade for GoodRx Holdings, Inc. has moved from fair to expensive, indicating that the company is overvalued. Key valuation ratios highlight this assessment, with a P/E ratio of 38, an EV to EBITDA of 9.64, and a Price to Book Value of 2.23, all suggesting that the stock is trading at a premium compared to its earnings and assets.\n\nIn comparison to peers, GoodRx's P/E ratio is significantly higher than that of PropertyGuru Group Ltd., which has a P/E of -132.05, and ZipRecruiter, Inc., which stands at -12.45, indicating that GoodRx is priced much higher relative to its earnings potential. Furthermore, the company's recent stock performance shows a 1-week return of 12.13%, outperforming the S&P 500's 1.09%, but over the longer term, the stock has underperformed, with a 1-year return of -34.16% compared to the S&P 500's 17.82%. This reinforces the notion that GoodRx is curre..."
      },
      {
        "title": "GoodRx Holdings, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/goodrx-holdings-changes-valuation-grade-from-fair-to-expensive-amid-price-fluctuations-3579939",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/GoodRxHoldingsI_valuationdot_3579939.png",
        "date": "2025-09-29 16:14:19",
        "description": "GoodRx Holdings, Inc. has recently adjusted its valuation, with a P/E ratio of 38 and a price-to-book value of 2.23. The company reports a return on capital employed of 11.40% and a return on equity of 5.92%, reflecting its operational efficiency amid competitive pressures."
      }
    ],
    "total": 14,
    "sid": "1251030",
    "stock_news_url": "https://www.marketsmojo.com/news/goodrx-holdings-inc-1251030"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is GoodRx Holdings, Inc. overvalued or undervalued?

2025-11-23 11:12:38

As of 21 November 2025, the valuation grade for GoodRx Holdings, Inc. has moved from attractive to very attractive. Despite this positive change, the company appears to be overvalued based on its current P/E ratio of 38, which is significantly higher than the peer average of approximately 31.76 for similar companies. Additionally, the EV to EBITDA ratio stands at 9.64, indicating a premium compared to some peers, while the Price to Book Value is 2.23, suggesting that the market is pricing the stock at a higher value relative to its book value. When compared to its peers, GoodRx's valuation ratios indicate a disparity, particularly against PropertyGuru Group Ltd. and ZipRecruiter, Inc., which have P/E ratios of -132.05 and -12.45, respectively. This context highlights that GoodRx's valuation may not be justified given its performance metrics, such as a ROE of 5.92% and a ROCE of 11.40%. Furthermore, the com...

GoodRx Holdings Hits 52-Week Low at $3.21 Amidst Significant Decline

2025-11-05 16:53:33

GoodRx Holdings, Inc. has hit a new 52-week low, reflecting a significant decline over the past year. Despite this downturn, the company reported positive financial metrics, including strong operating cash flow and net profit. Institutional investors maintain a substantial stake, indicating confidence in its fundamentals.

GoodRx Holdings Hits 52-Week Low at $3.25 Amid Significant Decline

2025-11-04 18:04:29

GoodRx Holdings, Inc. has reached a new 52-week low, reflecting a significant decline over the past year. Despite this downturn, the company reported strong financial metrics, including high operating cash flow and net profit. GoodRx also has a substantial market capitalization and high institutional ownership, indicating investor confidence.

Is GoodRx Holdings, Inc. overvalued or undervalued?

2025-10-21 12:13:36

As of 17 October 2025, GoodRx Holdings, Inc. has moved from an attractive to a fair valuation grade. The company appears to be overvalued based on its current metrics. Key ratios include a P/E ratio of 38, a Price to Book Value of 2.23, and an EV to EBITDA of 9.64, which suggest that the stock is priced higher relative to its earnings and book value compared to its peers. In comparison to its peers, GoodRx's P/E ratio of 31.76 is significantly better than PropertyGuru Group Ltd., which has a P/E of -132.05, indicating that GoodRx is relatively more stable in terms of earnings. However, the overall industry context suggests that GoodRx is not a strong performer, especially when considering its recent stock performance; it has underperformed the S&P 500 across multiple time frames, including a staggering -44.33% return over the past year compared to the S&P 500's 14.08%....

Is GoodRx Holdings, Inc. overvalued or undervalued?

2025-10-20 12:30:49

As of 17 October 2025, GoodRx Holdings, Inc. has moved from an attractive to a fair valuation grade. Based on the current metrics, the company appears to be fairly valued. The P/E ratio stands at 38, which is significantly higher than the peer average of approximately 31.76 for GoodRx, while the EV to EBITDA ratio of 9.64 is more favorable compared to the industry average. Additionally, the Price to Book Value is 2.23, indicating a reasonable valuation relative to its book value. In comparison to its peers, GoodRx Holdings, Inc. has a more favorable EV to EBITDA ratio than PropertyGuru Group Ltd., which has a ratio of 144.58, and significantly better than other risky peers like ZipRecruiter, Inc. and Cardlytics, Inc. Despite the lack of recent return data, the absence of a notable return comparison against the S&P 500 suggests that the stock's performance may not have been particularly strong, which aligns...

Is GoodRx Holdings, Inc. overvalued or undervalued?

2025-10-19 12:08:03

As of 17 October 2025, the valuation grade for GoodRx Holdings, Inc. has moved from attractive to fair. The company appears to be overvalued based on its current metrics. Key ratios include a P/E ratio of 38, a Price to Book Value of 2.23, and an EV to EBITDA of 9.64, which are relatively high compared to peers like PropertyGuru Group Ltd. with a P/E of -132.05 and ZipRecruiter, Inc. with a P/E of -12.45, both indicating significant challenges in their valuations. GoodRx has experienced substantial declines in stock performance, with a 1-year return of -44.33% compared to the S&P 500's 14.08%, and a staggering 5-year return of -92.78% against the S&P 500's 91.29%. This stark contrast reinforces the notion that GoodRx is currently overvalued in its market position....

GoodRx Holdings, Inc. Experiences Valuation Adjustment Amidst Competitive Market Landscape

2025-10-07 19:12:56

GoodRx Holdings, Inc. has recently adjusted its valuation, with a P/E ratio of 38 and a Price to Book Value of 2.23. The company shows mixed performance metrics, including a year-to-date return of -1.51% and a decline of 35.40% over the past year, compared to the S&P 500.

Is GoodRx Holdings, Inc. overvalued or undervalued?

2025-10-05 11:16:40

As of 3 October 2025, the valuation grade for GoodRx Holdings, Inc. has moved from fair to expensive, indicating that the company is overvalued. Key valuation ratios highlight this assessment, with a P/E ratio of 38, an EV to EBITDA of 9.64, and a Price to Book Value of 2.23, all suggesting that the stock is trading at a premium compared to its earnings and assets. In comparison to peers, GoodRx's P/E ratio is significantly higher than that of PropertyGuru Group Ltd., which has a P/E of -132.05, and ZipRecruiter, Inc., which stands at -12.45, indicating that GoodRx is priced much higher relative to its earnings potential. Furthermore, the company's recent stock performance shows a 1-week return of 12.13%, outperforming the S&P 500's 1.09%, but over the longer term, the stock has underperformed, with a 1-year return of -34.16% compared to the S&P 500's 17.82%. This reinforces the notion that GoodRx is curre...

GoodRx Holdings, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Pressures

2025-09-29 16:14:19

GoodRx Holdings, Inc. has recently adjusted its valuation, with a P/E ratio of 38 and a price-to-book value of 2.23. The company reports a return on capital employed of 11.40% and a return on equity of 5.92%, reflecting its operational efficiency amid competitive pressures.

View All News